The combination of colesevelam with sitagliptin enhances glycemic control in diabetic ZDF rat model. [electronic resource]
Producer: 20120529Description: G815-23 p. digitalISSN:- 1522-1547
- Allylamine -- analogs & derivatives
- Animals
- Anticholesteremic Agents -- therapeutic use
- Apoptosis -- drug effects
- Bile Acids and Salts -- metabolism
- Blood Glucose -- metabolism
- Body Weight -- drug effects
- Cell Proliferation -- drug effects
- Cell Size -- drug effects
- Colesevelam Hydrochloride
- Diabetes Mellitus, Type 2 -- blood
- Diet
- Drug Synergism
- Fluorescent Antibody Technique
- Glucagon-Like Peptide 1 -- blood
- Glucose Tolerance Test
- Hypoglycemic Agents -- therapeutic use
- In Situ Nick-End Labeling
- Insulin -- blood
- Insulin-Secreting Cells -- drug effects
- Ki-67 Antigen -- metabolism
- Male
- Postprandial Period -- physiology
- Pyrazines -- therapeutic use
- RNA, Messenger -- biosynthesis
- Rats
- Rats, Zucker
- Receptors, G-Protein-Coupled -- biosynthesis
- Sitagliptin Phosphate
- Triazoles -- therapeutic use
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
There are no comments on this title.
Log in to your account to post a comment.